MedTrace Logo

Bioabsorbable/Nufairy Coil Application Trial in China

NCT06466564 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2024-06-20

No results posted yet for this study

Summary

The scope of this trial is the collection and analysis of effectiveness and safety endpoints, related to the use of the Bioabsorbable/Nufairy Coil Embolization System in the treatment of intracranial aneurysms.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Nufairy® Coil embolization system for intracranial aneurysm

Nufairy® Coil embolization system for intracranial aneurysm

Sponsors & Collaborators

  • MicroPort NeuroTech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jianmin Liu · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-24
Primary Completion
2025-10-31
Completion
2026-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06466564 on ClinicalTrials.gov